This guide summarizes recommendations developed by the National Asthma Education and Prevention Program’s expert panel after conducting a systematic review of the scientific …

This SMART treatment option may be prescribed to those with moderate to severe persistent asthma, as a daily controller medication (ICS/ formoterol) and/or to treat rapid onset of …

= GENERIC AVAILABLE DISEASE STATES: = ASTHMA Respiratory 2025 Treatments 800.878.4403 • AllergyAsthmaNetwork.org Allergy & Asthma Network is a national nonprofit …

At the time of initial assessment (may consider pre and post bronchodilator to assess response) After treatment is initiated and symptoms stabilized to document “near” normal airway function …

GINA now recommends that all adults and adolescents with asthma should receive ICS-containing controller treatment. This can be either symptom-driven (in mild asthma, GINA …

Once a patient has been classified for the level of severity of their asthma, the health care provider can use the stepwise approach to gain or maintain control the patient’s asthma.

Global Strategy for Asthma Management and Prevention, 2025. Updated May 2025. Available from: www.ginasthma.org.

Regular use of SABA may indicate poor asthma control (e.g., > 2X per week; > 2 SABA inhalers per year). Paradoxical bronchospasm is unusual (~4%) and may be related to the propellant. …

For treatment purposes, patients who had 2 exacerbations requiring oral systemic corticosteroids in the past year may be considered the same as patients who have not-well-controlled asthma, …

Taking medicine as prescribed by your healthcare provider, avoiding asthma triggers, and following your Asthma Action Plan will you keep your asthma under good control.